SK Chemicals to release new gout medication
Published: 2009-07-07 06:58:00
Updated: 2009-07-07 06:58:00
SK Chemicals announced on July 2 that it received the marketing approval of Febuxostat 80 mg (brand name: Feburic), an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and gout, by the Korea Food and Drug Administration.
The company is expected to launc...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
